Peptide YY (3-36) Completed Phase 1 Trials for Healthy Volunteers (HV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00468884Oral Administration of Peptides; Absorption From Gastrointestinal Tract